Home > Insider Trading > Filing (0001209191-14-022943)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197036	I Bruce Sachs	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2014-03-21	2,450	$73.53	27,460	No	4	S	Direct
Common Stock	Disposition	2014-03-21	2,750	$74.47	24,710	No	4	S	Direct
Common Stock	Disposition	2014-03-21	3,000	$75.25	21,710	No	4	S	Direct
Common Stock	Disposition	2014-03-21	500	$76.57	21,210	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $73.53 (range $72.99 to $73.98).
Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $74.47 (range $73.99 to $74.96).
Open market sales reported on this line occurred at a weighted average price of $75.25 (range $75.00 to $75.85).
Open market sales reported on this line occurred at a weighted average price of $76.57 (range $76.22 to $76.74).